These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17524529)

  • 1. A new approach to the definition of seroconversion following vaccination in a population with high background antibody concentrations.
    Chandramohan D; Coleman P; Nelson C; Greenwood B
    Vaccine; 2007 Sep; 25 Suppl 1():A58-62. PubMed ID: 17524529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.
    Chandramohan D; Hodgson A; Coleman P; Baiden R; Asante K; Awine E; Owusu-Agyei S; Boutriau D; Nelson CB; Greenwood B
    Vaccine; 2007 Sep; 25 Suppl 1():A83-91. PubMed ID: 17521782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II meningococcal B vesicle vaccine trial in New Zealand infants.
    Jackson C; Lennon DR; Sotutu VT; Yan J; Stewart JM; Reid S; Crengle S; Oster P; Ypma E; Aaberge I; Mulholland K; Martin DR
    Arch Dis Child; 2009 Oct; 94(10):745-51. PubMed ID: 18838420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine.
    Wong SH; Lennon DR; Jackson CM; Stewart JM; Reid S; Ypma E; O'Hallahan JM; Oster P; Mulholland K; Martin DR
    Pediatr Infect Dis J; 2009 May; 28(5):385-90. PubMed ID: 19384263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues surrounding standardization of meningococcal group W135 serology.
    Balmer P; Borrow R
    Vaccine; 2007 Sep; 25 Suppl 1():A63-8. PubMed ID: 17544550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults.
    Kshirsagar N; Mur N; Thatte U; Gogtay N; Viviani S; Préziosi MP; Elie C; Findlow H; Carlone G; Borrow R; Parulekar V; Plikaytis B; Kulkarni P; Imbault N; LaForce FM
    Vaccine; 2007 Sep; 25 Suppl 1():A101-7. PubMed ID: 17532101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand.
    Oster P; O'Hallahan J; Aaberge I; Tilman S; Ypma E; Martin D
    Vaccine; 2007 Apr; 25(16):3075-9. PubMed ID: 17289223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower antibody functionality in middle-aged adults compared to adolescents after primary meningococcal vaccination: Role of IgM.
    van der Heiden M; van Ravenhorst MB; Bogaard M; Boots AMH; Berbers GAM; Buisman AM
    Exp Gerontol; 2018 May; 105():101-108. PubMed ID: 29287771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
    Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
    Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].
    Gong J; Li CY; Dong BQ; Huang JZ; Quan Y; Lu WZ; Luo CH; Mao WC; Liao HZ; Fang JS; Cui XL; Xie GL; Wu XH; Lan RW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):552-5. PubMed ID: 19040035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies.
    Rezaei N; Aghamohammadi A; Siadat SD; Nejati M; Ahmadi H; Moin M; Pourpak Z; Kamali S; Norouzian D; Tabaraei B; Read RC
    Vaccine; 2007 Jul; 25(29):5308-14. PubMed ID: 17574314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand.
    Lennon D; Jackson C; Wong S; Horsfall M; Stewart J; Reid S
    Clin Infect Dis; 2009 Aug; 49(4):597-605. PubMed ID: 19622040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Against meningococcus: a new form of vaccination].
    Triau R; Merieux C
    Bull Acad Natl Med; 1979 Mar; 163(3):277-88. PubMed ID: 15672589
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.
    Lee CH; Kuo WC; Beri S; Kapre S; Joshi JS; Bouveret N; LaForce FM; Frasch CE
    Vaccine; 2009 Jan; 27(5):726-32. PubMed ID: 19063929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV/Hib vaccine in healthy infants.
    Schmitt HJ; Steul KS; Borkowski A; Ceddia F; Ypma E; Knuf M
    Vaccine; 2008 Apr; 26(18):2242-52. PubMed ID: 18407386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconsideration of the use of meningococcal polysaccharide vaccine.
    Granoff DM; Pollard AJ
    Pediatr Infect Dis J; 2007 Aug; 26(8):716-22. PubMed ID: 17848884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reactive vaccination on meningitis epidemics in Southern Ethiopia.
    Cuevas LE; Savory EC; Hart CA; Thomson MC; Yassin MA
    J Infect; 2007 Nov; 55(5):425-30. PubMed ID: 17767960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningitis. Less vaccine can be more.
    Enserink M
    Science; 2008 Dec; 322(5907):1449. PubMed ID: 19056945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.